Literature DB >> 23723522

Cutaneous metastasis of neuroendocrine carcinoma.

Catharina Fluehler1, Laura Quaranta, Nicola di Meo, Bruno Ulessi, Giusto Trevisan.   

Abstract

Entities:  

Year:  2013        PMID: 23723522      PMCID: PMC3667334          DOI: 10.4103/0019-5154.110890

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Dear Editor, The skin is a relatively uncommon site for distant metastatic deposits, compared with organ such as liver, bone, and lung. The most common sources of cutaneous metastases are: Breast, skin tumors, lung, colon, stomach, upper aerodigestive tract, uterus, and kidney.[1] We describe the case of a 65-year-old patient, male, presented with a non-tender nodule, exophytic, rounded, of parenchymatous consistency, at the right rima oris, of around 2 cm in diameter, pinkish-purple colored, translucent lined by multiple telangiectasia [Figure 1].
Figure 1

A nodule upper right of rima oris

A nodule upper right of rima oris The patient was operated 2 years before for poorly-differentiated carcinoma at the rectum with multiple secondary lesions. The histological examination showed a solid pattern with nidus aspects of the pseudoglandular type [Figure 2], revealed as a neuroendocrine carcinoma.
Figure 2

Section of skin with H and E, staining ×20

Section of skin with H and E, staining ×20 To confirm the neuroendocrine differentiation, immunohistochemical investigations were made with following results: Chromogranin A−, synaptophysin+++, CK7−, CK20−, Neuron-Specific Enolase (NSE) - [Figure 3]. Considering his anamnesis and a diagnosis of a possible skin metastatic lesion, we performed an immunohistochemical analysis of the biopsy samples of the rectal carcinoma. The immunohistochemical panel confirms a strong positivity for synaptophysin and negativity for chromogranin A, CK7, CK20, NSE [Figure 4].
Figure 3

Detail of the skin neoplasia with synaptophysin staining

Figure 4

Detail of the rectal neoplasia with synaptophysin staining

Detail of the skin neoplasia with synaptophysin staining Detail of the rectal neoplasia with synaptophysin staining Neuroendocrine tumors (NETs) are rare malignant neoplasia, which are more frequent at the intestinal level where they represent, however, less than 1% of tumors.[2-4] Metastatic neuroendocrine carcinomas to the skin are infrequent and need to be differentiated from primary neuroendocrine skin tumors, in particular, from Merkel cell carcinoma. In the case presented here, the diagnosis of metastasis seemed likely since the patient had already diffuse metastatic disease at presentation and was confirmed by a comparative immunohistochemical study of both tumors (cutaneous and rectal). The most common sources of cutaneous metastasis are breast, melanoma, lung, colon, stomach, upper aereodigestive-tract, uterus, and kidney. The most common skin metastasis from a previously uncommon primary tumor originates from the kidney, lung, thyroid, or ovary.[4-6] Neuroendocrine cell (NEC) carcinomas of the colon and rectum are uncommon, comprising less than 1% of colon and rectal cancer. NEC carcinomas typically stain for the immunohistochemical markers synaptophysin, chromogranin, or neuron-specific enolase. It is well-known that NEC carcinomas of the colon and rectum has very poor prognosis.[7-8] The synaptophysine is a transmembrane glycoprotein with a molecular weight of 38 kDa and is a specific marker of neuroendocrinal differentiation. The synaptophysine has been identified in diverse primary neuroendocrine (NE) tumors of both neural and epithelial origin. In literature, there are many studies that confirm that expression of synaptophysin can be maintained during formation of metastases of several types of NE tumors, including medullary thyroid carcinoma, gastrinoma, insulinoma, small (oat) cell carcinoma of the lung, gastrointestinal carcinoid, and neuroblastoma, Synaptophysin immunohistochemical study is widely used for the positive identification of metastatic NE tumors, notably in differential diagnosis, as in our case report.[9] We would also like to draw attention to the diagnostic role of skin metastases which, in 7% of cases, according to the literature, may represent the first manifestation of an occult carcinoma, but coincide with a rapid progression of neoplastic disease.[10]
  8 in total

1.  Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting.

Authors:  B Wiedenmann; C Kuhn; K Schwechheimer; R Waldherr; F Raue; W E Brandeis; B Kommerell; W W Franke
Journal:  Am J Clin Pathol       Date:  1987-11       Impact factor: 2.493

Review 2.  Poorly differentiated neuroendocrine cell carcinoma of the rectum: report of a case and literal review.

Authors:  Hidenori Miyamoto; Nobuhiro Kurita; Masanori Nishioka; Tsutomu Ando; Takashi Tashiro; Mitsuyoshi Hirokawa; Mitsuo Shimada
Journal:  J Med Invest       Date:  2006-08

3.  Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.

Authors:  P Grabowski; I Schindler; I Anagnostopoulos; H D Foss; E O Riecken; U Mansmann; H Stein; G Berger; H J Buhr; H Scherübl
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 2.566

4.  Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.

Authors:  Patricia Grabowski; Julia Schönfelder; Gudrun Ahnert-Hilger; Hans-Dieter Foss; Bernhard Heine; Isabell Schindler; Harald Stein; Gerd Berger; Martin Zeitz; Hans Scherübl
Journal:  Virchows Arch       Date:  2002-06-07       Impact factor: 4.064

5.  Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.

Authors:  T J Saclarides; D Szeluga; E D Staren
Journal:  Dis Colon Rectum       Date:  1994-07       Impact factor: 4.585

6.  Cutaneous infiltration by cancer.

Authors:  Joaquim Marcoval; Abelardo Moreno; Jordi Peyrí
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

Review 7.  Cutaneous metastatic disease.

Authors:  R A Schwartz
Journal:  J Am Acad Dermatol       Date:  1995-08       Impact factor: 11.527

8.  Small cell neuroendocrine carcinoma of the rectum.

Authors:  M Vilor; Y Tsutsumi; R Y Osamura; N Tokunaga; J Soeda; M Ohta; H Nakazaki; Y Shibayama; F Ueno
Journal:  Pathol Int       Date:  1995-08       Impact factor: 2.534

  8 in total
  2 in total

1.  Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.

Authors:  Gemma Bruera; Antonio Giuliani; Lucia Romano; Alessandro Chiominto; Alessandra Di Sibio; Stefania Mastropietro; Pierluigi Cosenza; Enrico Ricevuto; Mario Schietroma; Francesco Carlei
Journal:  BMC Cancer       Date:  2019-10-16       Impact factor: 4.430

2.  Cutaneous Metastasis of Neuroendocrine Carcinoma with Unknown Primary Site: Case Report and Review of the Literature.

Authors:  Gustavo Moreira Amorim; Danielle Quintella; Tullia Cuzzi; Rosangela Rodrigues; Marcia Ramos-E-Silva
Journal:  Case Rep Dermatol       Date:  2015-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.